MXPA02012092A - Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos. - Google Patents
Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.Info
- Publication number
- MXPA02012092A MXPA02012092A MXPA02012092A MXPA02012092A MXPA02012092A MX PA02012092 A MXPA02012092 A MX PA02012092A MX PA02012092 A MXPA02012092 A MX PA02012092A MX PA02012092 A MXPA02012092 A MX PA02012092A MX PA02012092 A MXPA02012092 A MX PA02012092A
- Authority
- MX
- Mexico
- Prior art keywords
- parkinson
- disease
- treatment
- mammalian organs
- protein extractable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invencion se refiere a un metodo de tratamiento de pacientes sufriendo de la enfermedad de Parkinson que comprende la administracion de una cantidad eficaz de una proteina 14 kDa extraible de organos mamiferos, particularmente del higado de mamifero.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21003200P | 2000-06-08 | 2000-06-08 | |
PCT/EP2001/006337 WO2001093894A2 (en) | 2000-06-08 | 2001-06-04 | A method of treatment of parkinson's disease with a protein extractable from mammalian organs |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012092A true MXPA02012092A (es) | 2004-08-19 |
Family
ID=22781327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012092A MXPA02012092A (es) | 2000-06-08 | 2001-06-04 | Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030162704A1 (es) |
EP (1) | EP1286685A2 (es) |
JP (1) | JP2003535141A (es) |
AU (1) | AU2001262340A1 (es) |
CA (1) | CA2411430A1 (es) |
MX (1) | MXPA02012092A (es) |
WO (1) | WO2001093894A2 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1244879B (it) * | 1990-12-11 | 1994-09-12 | Alberto Bartorelli | Estratti da tessuti animali, utili in terapia e in diagnostica. |
IT1290828B1 (it) * | 1997-03-25 | 1998-12-11 | Zetesis Spa | Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche |
-
2001
- 2001-06-04 AU AU2001262340A patent/AU2001262340A1/en not_active Abandoned
- 2001-06-04 US US10/297,670 patent/US20030162704A1/en not_active Abandoned
- 2001-06-04 WO PCT/EP2001/006337 patent/WO2001093894A2/en not_active Application Discontinuation
- 2001-06-04 CA CA002411430A patent/CA2411430A1/en not_active Abandoned
- 2001-06-04 EP EP01936431A patent/EP1286685A2/en not_active Withdrawn
- 2001-06-04 JP JP2002501465A patent/JP2003535141A/ja active Pending
- 2001-06-04 MX MXPA02012092A patent/MXPA02012092A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003535141A (ja) | 2003-11-25 |
WO2001093894A2 (en) | 2001-12-13 |
EP1286685A2 (en) | 2003-03-05 |
US20030162704A1 (en) | 2003-08-28 |
CA2411430A1 (en) | 2001-12-13 |
AU2001262340A1 (en) | 2001-12-17 |
WO2001093894A3 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004066805A3 (en) | In vivo device for improving diastolic ventricular function | |
AU2003205077A1 (en) | Imaging agents and methods of imaging naaladase of psma | |
ATE442862T2 (de) | Niederviskose konzentrierte proteinformulierungen | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
FR12C0004I1 (es) | ||
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
MXPA03007590A (es) | Composiciones y metodos para mejorar suministro de droga a traves de y dentro de tejidos oculares. | |
IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
IL146125A0 (en) | Novel quinones as disease therapies | |
MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
ZA200003768B (en) | Methods and compositions for treating diseases and conditions of the eye. | |
GB9907571D0 (en) | Compounds | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
AU2001245319A1 (en) | Methods of treating diseases with activated protein c | |
WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers | |
PT1150703E (pt) | Terapia de esclerose multipla com chaperonina 10 e beta-interferao | |
NO20054034L (no) | Fremgangsmate for behandling av hypotyroidisme. | |
MXPA02012089A (es) | Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos. | |
MXPA02012092A (es) | Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos. | |
SG156658A1 (en) | Treatment of diseases | |
WO2002066075A3 (en) | Biotin-derivatives and their conjugates with chelating agents | |
MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
MXPA02012091A (es) | Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero. |